These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24301060)

  • 21. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor.
    Dewire MD; Ellison DW; Patay Z; McKinnon PJ; Sanders RP; Gajjar A
    Pediatr Blood Cancer; 2009 Dec; 53(6):1140-2. PubMed ID: 19530235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood.
    Hirsch B; Shimamura A; Moreau L; Baldinger S; Hag-alshiekh M; Bostrom B; Sencer S; D'Andrea AD
    Blood; 2004 Apr; 103(7):2554-9. PubMed ID: 14670928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression.
    Chen X; Truong TT; Weaver J; Bove BA; Cattie K; Armstrong BA; Daly MB; Godwin AK
    Hum Mutat; 2006 May; 27(5):427-35. PubMed ID: 16619214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The zebrafish kidney mutant zeppelin reveals that brca2/fancd1 is essential for pronephros development.
    Kroeger PT; Drummond BE; Miceli R; McKernan M; Gerlach GF; Marra AN; Fox A; McCampbell KK; Leshchiner I; Rodriguez-Mari A; BreMiller R; Thummel R; Davidson AJ; Postlethwait J; Goessling W; Wingert RA
    Dev Biol; 2017 Aug; 428(1):148-163. PubMed ID: 28579318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.
    Machackova E; Foretova L; Lukesova M; Vasickova P; Navratilova M; Coene I; Pavlu H; Kosinova V; Kuklova J; Claes K
    BMC Cancer; 2008 May; 8():140. PubMed ID: 18489799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.
    Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiplexed CRISPR/Cas9-mediated knockout of 19 Fanconi anemia pathway genes in zebrafish revealed their roles in growth, sexual development and fertility.
    Ramanagoudr-Bhojappa R; Carrington B; Ramaswami M; Bishop K; Robbins GM; Jones M; Harper U; Frederickson SC; Kimble DC; Sood R; Chandrasekharappa SC
    PLoS Genet; 2018 Dec; 14(12):e1007821. PubMed ID: 30540754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling.
    Meyer S; Tischkowitz M; Chandler K; Gillespie A; Birch JM; Evans DG
    J Med Genet; 2014 Feb; 51(2):71-5. PubMed ID: 24259538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fanconi Anemia, Complementation Group D1 Caused by Biallelic Mutations of BRCA2 Gene--Case Report].
    Puchmajerová A; Švojgr K; Novotná D; Macháčková E; Sumerauer D; Smíšek P; Kodet R; Kynčl M; Křepelová A; Foretová L
    Klin Onkol; 2016; 29 Suppl 1():S89-92. PubMed ID: 26691948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.
    Guénard F; Labrie Y; Ouellette G; Joly Beauparlant C; Simard J; ; Durocher F
    J Hum Genet; 2008; 53(7):579. PubMed ID: 18414782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.
    Thomassen M; Blanco A; Montagna M; Hansen TV; Pedersen IS; Gutiérrez-Enríquez S; Menéndez M; Fachal L; Santamariña M; Steffensen AY; Jønson L; Agata S; Whiley P; Tognazzo S; Tornero E; Jensen UB; Balmaña J; Kruse TA; Goldgar DE; Lázaro C; Diez O; Spurdle AB; Vega A
    Breast Cancer Res Treat; 2012 Apr; 132(3):1009-23. PubMed ID: 21769658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
    Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
    DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catastrophic chemotherapy toxicity leading to diagnosis of Fanconi anaemia due to
    Ip E; McNeil C; Grimison P; Scheinberg T; Tudini E; Ho G; Scott RJ; Brown C; Sandroussi C; Guitera P; Spurdle AB; Goodwin A
    J Med Genet; 2022 Sep; 59(9):912-915. PubMed ID: 34697207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
    Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia.
    Pouliot GP; Degar J; Hinze L; Kochupurakkal B; Vo CD; Burns MA; Moreau L; Ganesa C; Roderick J; Peirs S; Menten B; Loh ML; Hunger SP; Silverman LB; Harris MH; Stevenson KE; Weinstock DM; Weng AP; Van Vlierberghe P; D'Andrea AD; Gutierrez A
    PLoS One; 2019; 14(11):e0221288. PubMed ID: 31721781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fanconi anaemia and cancer: an intricate relationship.
    Nalepa G; Clapp DW
    Nat Rev Cancer; 2018 Mar; 18(3):168-185. PubMed ID: 29376519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fanconi anemia-D1 due to homozygosity for the BRCA2 gene Cypriot founder mutation: A case report.
    Loizidou MA; Hadjisavvas A; Tanteles GA; Spanou-Aristidou E; Kyriacou K; Christophidou-Anastasiadou V
    Oncol Lett; 2016 Jan; 11(1):471-473. PubMed ID: 26834852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
    Meindl A;
    Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2.
    Claes K; Poppe B; Machackova E; Coene I; Foretova L; De Paepe A; Messiaen L
    Genes Chromosomes Cancer; 2003 Jul; 37(3):314-20. PubMed ID: 12759930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.